Novartis slashes New Jersey workforce again, cutting 322 employees

{
  "signal_id": "74026505-3953-783b-194c-bb879428695f",
  "signal_type": "news",
  "signal_subtype": "closes_offices_in",
  "detected_at": "2026-07-07T14:55:06+00:00",
  "company": {
    "name": "Novartis",
    "domain": "novartis.com"
  },
  "data": {
    "url": "https://www.biospace.com/job-trends/novartis-slashes-new-jersey-workforce-again-cutting-322-employees",
    "title": "Novartis slashes New Jersey workforce again, cutting 322 employees - BioSpace",
    "assets": "production site",
    "excerpt": "In its largest round of layoffs this year, Novartis is trimming its East Hanover, New Jersey, workforce for a fourth time, letting go of 322 employees and bringing the total number of affected people at that location to 572. The cuts are effective Oct. 2, according to a Worker Adjustment and Retraining Notification (WARN) Act notice . The first three rounds of layoffs at the Swiss pharma’s East Hanover location were disclosed in March, April and May, affecting 114, 60 and 76 employees, respectively. All cuts are effective this year. In total, Novartis has announced or disclosed in 2026 that it’s letting go of at least 792 employees. In May, the pharma confirmed to BioSpace that it’s laying off a “select number” of staff within its biomedical research association. That same month, the company announced it will shut down a production site in Wehr, Germany, by the end of 2028, eliminating 220 jobs. That location, which makes solid oral dosage forms such as tablets and capsules for mostly established Novartis products, is no longer competitive, the company noted in its announcement. The pharma also cut its workforce in 2025 , laying off 1,069 employees, including 485 in East Hanover, over a multiyear period. Meanwhile, Novartis is making major moves, most recently in the cancer space. This week, the pharma announced an acquisition of Myricx Bio that’s worth up to $1.5 billion . As...",
    "summary": "Novartis plans to shut down a production site in Wehr, Germany, by the end of 2028, which will result in the elimination of 220 jobs.",
    "location": "Wehr, Germany",
    "planning": true,
    "headcount": 220,
    "image_url": "https://static.biospace.com/dims4/default/30c59bf/2147483647/strip/true/crop/1322x744+0+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F92%2F7e%2F1c2a4b174fe3839f3d3facfddb53%2Flayoffs-exit-door.jpg",
    "confidence": 0.9,
    "assets_tags": [
      "production"
    ],
    "published_at": "2026-07-07T14:55:06Z",
    "location_data": [
      {
        "city": "Wehr",
        "state": "Baden-Württemberg",
        "region": "Western Europe",
        "country": "Germany",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2028-12-31",
    "article_sentence": "That same month, the company announced it will shut down a production site in Wehr, Germany, by the end of 2028, eliminating 220 jobs."
  }
}

curl https://signals.autobound.ai/v1/signals/74026505-3953-783b-194c-bb879428695f \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"novartis.com","limit":20}'